completion of shares selling: 1) Sansiri holds shares in proportion of 50 percent 2) The Company holds shares in proportion of 50 percent Director Structure: 1. Ms. Piyaporn Phanachet 2. Mr. Sayam
of All S or current proportion of 6.25%. Therefore, the company has rights to purchase 175,000 ordinary shares at par value of 100 baht. In this regards, the company will increase its investment in
Administrative expenses 345.64 125.89 Cost of amortization 2.58 2.41 Finance costs 45.86 6.53 Finance costs (net) 37.80 3.10 Proportion of cost of medical treatment / revenue of medical treatment 73.97 67.76
Administrative expenses 311.52 148.24 Cost of amortization 4.15 3.02 Finance costs 53.71 9.04 Finance costs (net) 49.56 6.02 Proportion of cost of medical treatment / revenue of medical treatment 89.78 71.00
Philippines law, the newly issued shares will be offered to the existing shareholders in proportion to their rights. However, the Company will waive its right to subscribe CCPH's rights issue for the
2016 that had loss about 10.58 million baht to have profit in 2017 estimated at 0.69 million baht. The company received the profit in proportion of investment 60% of 0.41 million baht. 3. Legacy Asia
selling medical equipment 60.65 73.92 Administrative expenses 109.64 105.99 Finance costs 22.86 24.24 Finance costs (net) 20.87 21.71 Proportion of cost of medical treatment / revenue of medical treatment
590.59 553.11 Cost of selling medical equipment 65.30 57.70 Administrative expenses 112.97 109.49 Finance costs 19.32 24.93 Finance costs (net) 16.90 22.87 Proportion of cost of medical treatment / revenue
Company shall subscribe the newly issued share in proportion of 108,022 shares and the newly issued share in portion of the unsubscribed shares of other shareholders of 40,604 shares. As subscription of
pay and doctor fee. Selling Expenses The selling expenses for Year 2017 and 2018 were in amounts of Baht 15.03 million and Baht 15.83 million, inclining by 5.4%. The proportion of selling expenses